Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Avidity Biosciences, Inc. Director's Dealing 2021

Jan 12, 2021

30894_dirs_2021-01-11_2c4af93a-51a5-4758-9187-f6e0a4776002.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2021-01-11

Reporting Person: Kim Jean Jinsun (Director)

More from Avidity Biosciences, Inc.

Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
View all filings →